Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Corona, Carlo ^a   Frazzini, Valerio ^a   Silvestri, Elena ^b   Lattanzio, Rossano ^a   la Sorda, Rossana ^a   Piantelli, Mauro ^a   Canzoniero, Lorella M T ^b   Ciavardelli, Domenico ^a   Rizzarelli, Enrico ^c   Sensi, Stefano L ^a,d  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CARNOSINE; TAU PROTEIN; ZINC ION; AMYLOID; CHELATING AGENT; ZINC;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LONG TERM MEMORY; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; AGING; ANIMAL; DRUG EFFECT; INTRACELLULAR SPACE; MEMORY DISORDER; METABOLISM; MITOCHONDRION; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALIA; MUS;

AGING; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; CARNOSINE; CHELATING AGENTS; COGNITION DISORDERS; DIETARY SUPPLEMENTS; HIPPOCAMPUS; INTRACELLULAR SPACE; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NEURONS; TAU PROTEINS; ZINC;

EID: 79952642126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017971     Document Type: Article

References (53)

1. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
2. Sensi SL, Paoletti P, Bush AI, Sekler I, (2009) Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci 10: 780-791.
3. Crouch PJ, Cimdins K, Duce JA, Bush AI, Trounce IA, (2007) Mitochondria in aging and Alzheimer's disease. Rejuvenation Res 10: 349-357.
4. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, et al. (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A 106: 20057-20062.
5. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, et al. (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 106: 14670-14675.
6. Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, et al. (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265: 1464-1467.
7. Gazaryan IG, Krasinskaya IP, Kristal BS, Brown AM, (2007) Zinc irreversibly damages major enzymes of energy production and antioxidant defense prior to mitochondrial permeability transition. J Biol Chem 282: 24373-24380.
8. Sensi SL, Yin HZ, Carriedo SG, Rao SS, Weiss JH, (1999) Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci U S A 96: 2414-2419.
9. Adlard PA, Bush AI, (2006) Metals and Alzheimer's disease. J Alzheimers Dis 10: 145-163.
10. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY, (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A 99: 7705-7710.
11. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
12. Sensi SL, Rapposelli IG, Frazzini V, Mascetra N, (2008) Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp Gerontol 43: 488-492.
13. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, et al. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59: 43-55.
14. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665-676.
15. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, et al. (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7: 779-786.
16. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, et al. (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60: 1685-1691.
17. Quinn PJ, Boldyrev AA, Formazuyk VE, (1992) Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med 13: 379-444.
18. Horning MS, Blakemore LJ, Trombley PQ, (2000) Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine. Brain Res 852: 56-61.
19. Kohen R, Yamamoto Y, Cundy KC, Ames BN, (1988) Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci U S A 85: 3175-3179.
20. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN, (1998) Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 242: 105-108.
21. Trombley PQ, Horning MS, Blakemore LJ, (2000) Interactions between carnosine and zinc and copper: implications for neuromodulation and neuroprotection. Biochemistry (Mosc) 65: 807-816.
22. Trombley PQ, Horning MS, Blakemore LJ, (1998) Carnosine modulates zinc and copper effects on amino acid receptors and synaptic transmission. Neuroreport 9: 3503-3507.
23. Brownson C, Hipkiss AR, (2000) Carnosine reacts with a glycated protein. Free Radic Biol Med 28: 1564-1570.
24. Hipkiss AR, Brownson C, Carrier MJ, (2001) Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups. Mech Ageing Dev 122: 1431-1445.
25. Hipkiss AR, Michaelis J, Syrris P, (1995) Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 371: 81-85.
26. Hipkiss AR, Worthington VC, Himsworth DT, Herwig W, (1998) Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite. Biochim Biophys Acta 1380: 46-54.
27. Balion CM, Benson C, Raina PS, Papaioannou A, Patterson C, et al. (2007) Brain type carnosinase in dementia: a pilot study. BMC Neurol 7: 38.
28. Bellia F, Calabrese V, Guarino F, Cavallaro M, Cornelius C, et al. (2009) Carnosinase levels in aging brain: redox state induction and cellular stress response. Antioxid Redox Signal 11: 2759-2775.
29. Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG, (2007) Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids 32: 213-224.
30. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM, (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688.
31. Baran EJ, (2000) Metal complexes of carnosine. Biochemistry (Mosc) 65: 789-797.
32. Mineo P, Vitalini D, La Mendola D, Rizzarelli E, Scamporrino E, et al. (2002) Electrospray mass spectrometric studies of L-carnosine (beta-alanyl-L-histidine) complexes with copper(II) or zinc ions in aqueous solution. Rapid Commun Mass Spectrom 16: 722-729.
33. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, et al. (2000) Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 75: 1878-1888.
34. Sensi SL, Ton-That D, Sullivan PG, Jonas EA, Gee KR, et al. (2003) Modulation of mitochondrial function by endogenous Zn2+ pools. Proc Natl Acad Sci U S A 100: 6157-6162.
35. Sutherland RJ, McDonald RJ, (1990) Hippocampus, amygdala, and memory deficits in rats. Behav Brain Res 37: 57-79.
36. Corona C, Masciopinto F, Silvestri E, Del Viscovo A, Lattanzio R, et al. (2010) Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death and Dis 1: e91.
37. Boldyrev AA, (1994) Carnosine and free-radical defence mechanisms. Trends Neurosci 17: 468.
38. Lee JY, Kim JH, Hong SH, Lee JY, Cherny RA, et al. (2004) Estrogen decreases zinc transporter 3 expression and synaptic vesicle zinc levels in mouse brain. J Biol Chem 279: 8602-8607.
39. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, et al. (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216: 92-103.
40. Ittner LM, Gotz J, (2011) Amyloid-beta and tau- a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12: 65-72.
41. Calabrese V, Colombrita C, Guagliano E, Sapienza M, Ravagna A, et al. (2005) Protective effect of carnosine during nitrosative stress in astroglial cell cultures. Neurochem Res 30: 797-807.
42. Atamna H, Kumar R, (2010) Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase. J Alzheimers Dis 20 (Suppl 2): S439-452.
43. Brunden KR, Trojanowski JQ, Lee VM, (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 8: 783-793.
44. Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM, (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30: 7281-7289.
45. Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, et al. (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281: 39413-39423.
46. Stoltenberg M, Bush AI, Bach G, Smidt K, Larsen A, et al. (2007) Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Neuroscience 150: 357-369.
47. Adlard PA, Parncutt JM, Finkelstein DI, Bush AI, (2010) Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci 30: 1631-1636.
48. Odashima M, Otaka M, Jin M, Konishi N, Sato T, et al. (2002) Induction of a 72-kDa heat-shock protein in cultured rat gastric mucosal cells and rat gastric mucosa by zinc L-carnosine. Dig Dis Sci 47: 2799-2804.
49. Ueda K, Ueyama T, Oka M, Ito T, Tsuruo Y, et al. (2009) Polaprezinc (Zinc L-carnosine) is a potent inducer of anti-oxidative stress enzyme, heme oxygenase (HO)-1- a new mechanism of gastric mucosal protection. J Pharmacol Sci 110: 285-294.
50. Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S, (2010) CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 107: 22687-22692.
51. Sensi SL, Canzoniero LM, Yu SP, Ying HS, Koh JY, et al. (1997) Measurement of intracellular free zinc in living cortical neurons: routes of entry. J Neurosci 17: 9554-9564.
52. Schagger H, (1996) Electrophoretic techniques for isolation and quantification of oxidative phosphorylation complexes from human tissues. Methods Enzymol 264: 555-566.
53. Zerbetto E, Vergani L, Dabbeni-Sala F, (1997) Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels. Electrophoresis 18: 2059-2064.